EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

18F-Flortaucipir (AV1451) imaging identifies grey matter atrophy in retired athletes

Anna Vasilevskaya, Chloe Anastassiadis, Simrika Thapa, Foad Taghdiri, Mozhgan Khodadadi, Namita Multani, Pablo Rusjan, Miracle Ozzoude, Apameh Tarazi, Asma Mushtaque, Richard Wennberg, Sylvain Houle und 13 weitere

Journal of Neurology · 2024

DOI: 10.1007/s00415-024-12573-0 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Neurology, 2024. Verfasst von Anna Vasilevskaya und 24 weiteren Autor:innen. Beteiligte Einrichtung: Tanz Centre for Research in Neurodegenerative Diseases, University of Toronto, Krembil Discovery Tower, 60 Leonard Avenue, 6th Floor 6KD-407, Toronto…. Hauptthemen laut MEDLINE: Gray Matter, Positron-Emission Tomography, Atrophy, Athletes. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Hjärnfonden, NIA NIH HHS, Alzheimer's Drug Discovery Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The long-term consequences of concussions may include pathological neurodegeneration as seen in Alzheimer’s disease (AD) and chronic traumatic encephalopathy (CTE). Tau-PET showed promise as a method to detect tau pathology of CTE, but more studies are needed Objective This study aimed (1) to assess the association of imaging evidence of tau pathology with brain volumes in retired athletes and (2) to examine the relationship between tau-PET and neuropsychological functioning.

Methods

Former contact sport athletes were recruited through the Canadian Football League Alumni Association or the Canadian Concussion Centre clinic. Athletes completed MRI, [ 18 F]flortaucipir tau-PET, and a neuropsychological battery. Memory composite was created by averaging the Rey Auditory Verbal Learning Test and Rey Visual Design Learning Test z-scores. Grey matter (GM) volumes were age/intracranial volume corrected using normal control MRIs. Tau-PET % positivity in GM was calculated as the number of positive voxels (≥ 1.3 standardized uptake value ratio (SUVR)/total voxels).

Results

47 retired contact sport athletes negative for AD (age:51 ± 14; concussions/athlete:15 ± 2) and 54 normal controls (age:50 ± 13) were included. Tau-PET positive voxels had significantly lower GM volumes, compared to tau-PET negative voxels (− 0.37 ± 0.41 vs. − 0.31 ± 0.37, paired p = .006). There was a significant relationship between GM tau-PET % positivity and memory composite score (r = − .366, p = .02), controlled for age, PET scanner, and PET scan duration. There was no relationship between tau-PET measures and concussion number, or years of sport played.

Conclusion

A higher tau-PET signal was associated with reduced GM volumes and lower memory scores. Tau-PET may be useful for identifying those at risk for neurodegeneration.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gray MatterPositron-Emission TomographyAtrophyAthletesCarbolinestau ProteinsHumansMaleMiddle AgedAdultAgedBrain ConcussionRetirementMagnetic Resonance ImagingFemaleNeuropsychological TestsAthletic Injuries

Stichwörter der Autor:innen

AthletesChronic traumatic encephalopathyConcussionNeurodegenerationPetTau

Substanzen

Carbolinestau Proteins7-(6-fluoropyridin-3-yl)-5H-pyrido(4,3-b)indole

Autor:innen und Institutionen

  • Tanz Centre for Research in Neurodegenerative Diseases, University of Toronto, Krembil Discovery Tower, 60 Leonard Avenue, 6th Floor 6KD-407, Toronto, ON, M5T 2S8, Canada.
  • Institute of Medical Science, University of Toronto, Toronto, ON, Canada.
  • Division of Neurology, Toronto Western Hospital, University Health Network, Toronto, ON, Canada.
  • Canadian Concussion Centre, Toronto Western Hospital, Krembil Brain Institute, University Health Network, Toronto, ON, Canada.
  • Douglas Mental Health University Institute, Montreal, QC, Canada.
  • Department of Psychiatry, McGill University, Montreal, QC, Canada.

Förderung

  • Hjärnfonden
  • NIA NIH HHS
  • Alzheimer's Drug Discovery Foundation
  • Swedish Research Council
  • European Union Joint Program for Neurodegenerative Disorders
  • National Institute of Health (NIH)
  • AD Strategic Fund and the Alzheimer's Association
  • Swedish State Support for Clinical Research

Zitieren

APA

Vasilevskaya, A., Anastassiadis, C., Thapa, S., Taghdiri, F., Khodadadi, M., Multani, N., Rusjan, P., Ozzoude, M., Tarazi, A., Mushtaque, A., Wennberg, R., Houle, S., Green, R., Colella, B., Vasdev, N., Blennow, K., Zetterberg, H., Karikari, T., Sato, C., …, & Tartaglia, M. C. (2024). 18F-Flortaucipir (AV1451) imaging identifies grey matter atrophy in retired athletes. Journal of Neurology. https://doi.org/10.1007/s00415-024-12573-0

Vancouver

Vasilevskaya A, Anastassiadis C, Thapa S, Taghdiri F, Khodadadi M, Multani N, et al. 18F-Flortaucipir (AV1451) imaging identifies grey matter atrophy in retired athletes. Journal of Neurology. 2024. doi:10.1007/s00415-024-12573-0

BibTeX
@article{Vasilevskaya2024,
  author = {Vasilevskaya, Anna and Anastassiadis, Chloe and Thapa, Simrika and Taghdiri, Foad and Khodadadi, Mozhgan and Multani, Namita and Rusjan, Pablo and Ozzoude, Miracle and Tarazi, Apameh and Mushtaque, Asma and Wennberg, Richard and Houle, Sylvain and Green, Robin and Colella, Brenda and Vasdev, Neil and Blennow, Kaj and Zetterberg, Henrik and Karikari, Thomas and Sato, Christine and Moreno, Danielle and Rogaeva, Ekaterina and Mikulis, David and Davis, Karen Deborah and Tator, Charles and Tartaglia, Maria Carmela},
  title = {18F-Flortaucipir (AV1451) imaging identifies grey matter atrophy in retired athletes},
  journal = {Journal of Neurology},
  year = {2024},
  doi = {10.1007/s00415-024-12573-0}
}
Kostenlos starten →